Phenotypic and functional alterations on inflammatory peripheral blood cells after acute myocardial infarction

Journal of Cardiovascular Translational Research

Volumn 5, Issue 3, 2012, Pages 309-320

  Carvalheiro, Tiago ^a   Velada, Isabel ^a   Valado, Ana ^b   Mendes, Fernando ^b   Martinho, António ^a   António, Natália ^c   Gonçalves, Lino ^c   Providência, Luís ^c   Pais, Maria Luísa ^a   Paiva, Artur ^a  

^a Centro de Histocompatibilidade do Centro Coimbra   (Portugal)

^b Superior School of Health Technology of Coimbra   (Portugal)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Acute myocardial infarction; Dendritic cells; Inflammatory cytokines; Monocytes; Regulatory Tcells; Tcells

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IL2 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; MESSENGER RNA;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CTLA 4 GENE; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; FOXP3 GENE; GENE; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFLAMMATORY CELL; MALE; MONOCYTE; MYELOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; T LYMPHOCYTE; TGF BETA GENE; UPREGULATION; AGED; BLOOD; CASE CONTROL STUDY; CELL SEPARATION; GENETICS; HEART INFARCTION; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; PHENOTYPE; PORTUGAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; TIME;

ADULT; AGED; ANTIGENS, CD14; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL SEPARATION; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GPI-LINKED PROTEINS; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; PHENOTYPE; PORTUGAL; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, IGG; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865842044     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9365-8     Document Type: Article

References (54)

1. Alpert, J. S., Thygesen, K., Antman, E., & Bassand, J. P. (2000). Myocardial infarction redefined -A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology, 36(3), 959-969.
2. Sun, Y. (2009). Myocardial repair/remodelling following infarction: Roles of local factors. Cardiovascular Research, 81(3), 482-490. doi:10.1093/cvr/ cvn333.
3. Frangogiannis, N. G., Smith, C. W., & Entman, M. L. (2002). The inflammatory response in myocardial infarction. Cardiovascular Research, 53(1), 31-47. (Pubitemid 34020764)
4. Deten, A., Volz, H. C., Briest, W., & Zimmer, H. G. (2002). Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovascular Research, 55(2), 329-340. (Pubitemid 34775283)
5. Irwin, M. W., Mak, S., Mann, D. L., Qu, R., Penninger, J. M., Yan, A., et al. (1999). Tissue expression and immunolocalization of tumor necrosis factor-Alpha in postinfarction dysfunctional myocardium. Circulation, 99(11), 1492-1498. (Pubitemid 29140917)
6. Akasaka, Y., Morimoto, N., Ishikawa, Y., Fujita, K., Ito, K., Kimura-Matsumoto, M., et al. (2006). Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction. Modern Pathology, 19(4), 588-598. doi:10.1038/modpathol.3800568.
7. Frangogiannis, N. G. (2008). The immune system and cardiac repair. Pharmacological Research, 58(2), 88-111. doi:10.1016/j.phrs.2008.06.007.
8. Frangogiannis, N. G. (2006). The mechanistic basis of infarct healing. Antioxidants & Redox Signaling, 8(11-12), 1907-1939. doi:10.1089/ars.2006.8. 1907. (Pubitemid 46504897)
9. Nian, M., Lee, P., Khaper, N., & Liu, P. (2004). Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research, 94(12), 1543-1553. doi:10.1161/01.RES.0000130526.20854. (Pubitemid 38856961)
10. Biswas, S., Ghoshal, P. K., Mandal, S. C., & Mandal, N. (2010). Relation of anti-to pro-inflammatory cytokine ratios with acute myocardial infarction. The Korean Journal of Internal Medicine, 25(1), 44-50. doi:10.3904/kjim.2010.25.1.44.
11. Jiang, B., & Liao, R. (2010). The paradoxical role of inflammation in cardiac repair and regeneration. Journal of Cardiovascular Translational Research, 3(4), 410-416. doi:10.1007/s12265-010-9193-7.
12. Frantz, S., Bauersachs, J., & Ertl, G. (2009). Post-infarct remodelling: Contribution of wound healing and inflammation. Cardiovascular Research, 81(3), 474-481. doi:10.1093/cvr/cvn292.
13. Almeida, J., Bueno, C., Alguero, M. C., Sanchez, M. L., de Santiago, M., Escribano, L., et al. (2001). Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage/CD16(+)/HLA-DR(+)/CD14(lo) cells, CD14(+) monocytes, and CD16 dendritic cells. Clinical Immunology, 100(3), 325-338. doi:10.1006/clim.2001.5072.
14. Bueno, C., Almeida, J., Alguero, M. C., Sanchez, M. L., Vaquero, J. M., Laso, F. J., et al. (2001). Flow cytometric analysis of cytokine production by normal human peripheral blood dendritic cells and monocytes: Comparative analysis of different stimuli, secretion-blocking agents and incubation periods. Cytometry, 46 (1), 33-40. doi:10.1002/1097-0320(20010215). (Pubitemid 32216736)
15. MacDonald, K. P., Munster, D. J., Clark, G. J., Dzionek, A., Schmitz, J., & Hart, D. N. (2002). Characterization of human blood dendritic cell subsets. Blood, 100(13), 4512-4520. doi:10.1182/blood-2001-11-0097. (Pubitemid 35429692)
16. Crespo, I., Paiva, A., Couceiro, A., Pimentel, P., Orfao, A., & Regateiro, F. (2004). Immunophenotypic and functional characterization of cord blood dendritic cells. Stem Cells and Development, 13(1), 63-70. doi:10.1089/154732804773099263. (Pubitemid 38560043)
17. Henriques, A., Ines, L., Carvalheiro, T., Couto, M., Andrade, A., & Pedreiro, S. (2011). Functional characterization of peripheral blood dendritic cells and monocytes in systemic lupus erythematosus. Rheumatology International. doi:10.1007/s00296-010-1709-6.
18. Morgado, J. M., Pratas, R., Laranjeira, P., Henriques, A., Crespo, I., Regateiro, F., et al. (2008). The phenotypical and functional characteristics of cord blood monocytes and CD14(low)/CD16 (+) dendritic cells can be relevant to the development of cellular immune responses after transplantation. Transplant Immunology, 19(1), 55-63. doi:10.1016/j.trim.2007.11.002.
19. Henriques, A., Ines, L., Couto, M., Pedreiro, S., Santos, C., Magalhaes, M., et al. (2010). Frequency and functional activity of Th17, Tc17 and other T-cell subsets in systemic lupus erythematosus. Cellular Immunology, 264(1), 97-103. doi:10.1016/j.cellimm.2010.05.004.
20. Paiva, A., Ferreira, T., Freitas, A., Couceiro, A., Coimbra, H., & Regateiro, F. J. (2000). Profile of cytokine production in human cord blood and peripheral blood from healthy donors before and after allogeneic activation: Relevance in predicting graft-versus-host disease. Transplantation Proceedings, 32(8), 2626-2630. (Pubitemid 32008172)
21. Banham, A. H. (2006). Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends in Immunology, 27(12), 541-544. doi:10.1016/j.it.2006.10.002. (Pubitemid 44780852)
22. Caton, A. J., Cozzo, C., Larkin, J., 3rd, Lerman, M. A., Boesteanu, A., & Jordan, M. S. (2004). CD4(+) CD25(+) regulatory T cell selection. Annals of the New York Academy of Sciences, 1029, 101-114. doi:1029/1/101. (Pubitemid 40298522)
23. Corthay, A. (2009). How do regulatory T cells work? Scandinavian Journal of Immunology, 70(4), 326-336. doi:10.1111/j.1365-3083.2009.02308.x.
24. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. (2002) Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (7): RESEARCH0034.
25. Ren, G., Dewald, O., & Frangogiannis, N. G. (2003). Inflammatory mechanisms in myocardial infarction. Current Drug Targets. Inflammation and Allergy, 2(3), 242-256.
26. Tousoulis, D., Charakida, M., & Stefanadis, C. (2008). Endothelial function and inflammation in coronary artery disease. Postgraduate Medical Journal, 84(993), 368-371. doi :10.1136/hrt.2005.066936.
27. Tarzami, S. T. (2011). Chemokines and inflammation in heart disease: Adaptive or maladaptive? International Journal of Clinical Experimental Medicine, 4(1), 74-80.
28. Parissis, J. T., Adamopoulos, S., Venetsanou, K., Kostakis, G., Rigas, A., Karas, S. M., et al. (2004). Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction. European Cytokine Network, 15(2), 139-144. (Pubitemid 38980089)
29. Novo, G., Rizzo, M., La Carruba, S., Caruso, M., Amoroso, G. R., Balistreri, C. R., et al. (2011). The role of macrophage colonystimulating factor in patients with acute myocardial infarction: A pilot study. Angiology. doi:10.1177/0003319711409742.
30. Oren, H., Erbay, A. R., Balci, M., & Cehreli, S. (2007). Role of novel mediators of inflammation in left ventricular remodeling in patients with acute myocardial infarction: do they affect the outcome of patients? Angiology, 58(1), 45-54. doi:10.1177/0003319706297916.
31. Leone, A. M., Rutella, S., Bonanno, G., Contemi, A. M., de Ritis, D. G., Giannico, M. B., et al. (2006). Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. International Journal of Cardiology, 111(2), 202-208. doi:10.1016/j.ijcard.2005.06.043. (Pubitemid 44107557)
32. Nahrendorf, M., Pittet, M. J., & Swirski, F. K. (2010). Monocytes: Protagonists of infarct inflammation and repair after myocardial infarction. Circulation, 121(22), 2437-2445. doi:10.1161/CIRCULATIONAHA.109.916346.
33. Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J. L., et al. (2007). The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. The Journal of Experimental Medicine, 204(12), 3037-3047. doi:10.1084/jem.20070885. (Pubitemid 350179569)
34. Kofler, S., Sisic, Z., Shvets, N., Lohse, P., & Weis, M. (2011). Expression of circulatory dendritic cells and regulatory T-cells in patients with different subsets of coronary artery disease. Journal of Cardiovascular Pharmacology, 57(5), 542-549. doi:10.1097/FJC.0b013e3182124c53.
35. Tu, X. W., Li, Z. L., Liu, Y. F., & Wei, X. L. (2009). Classification and functional study of peripheral blood dendritic cells in patients with coronary artery disease with different atherosclerotic plaques. Nan Fang Yi Ke Da Xue Xue Bao, 29(6), 1195-1198.
36. Van Brussel, I., Van Vre, E. A., De Meyer, G. R., Vrints, C. J., Bosmans, J. M., & Bult, H. (2011). Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function. Clinical Science (London, England), 120(9), 415-426. doi:10.1042/CS20100440.
37. Van Vre, E. A., Hoymans, V. Y., Bult, H., Lenjou, M., Van Bockstaele, D. R., Vrints, C. J., et al. (2006). Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease. Coronary Artery Disease, 17(3), 243-248. (Pubitemid 44324834)
38. Dinman, J. D. (2005). 5S rRNA: structure and function from head to toe. International Journal of Biomedical Sciences, 1 (1), 2-7.
39. Tsujioka, H., Imanishi, T., Ikejima, H., Kuroi, A., Takarada, S., Tanimoto, T., et al. (2009). Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. Journal of the American College of Cardiology, 54(2), 130-138. doi:10.1016/j.jacc.2009.04.021.
40. Nah, D. Y., & Rhee, M. Y. (2009). The inflammatory response and cardiac repair after myocardial infarction. Korean Circulation Journal, 39(10), 393-398. doi:10.4070/kcj.2009.39.10.393.
41. Yip, H. K., Youssef, A. A., Chang, L. T., Yang, C. H., Sheu, J. J., Chua, S., et al. (2007). Association of interleukin-10 level with increased 30-day mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Circulation Journal, 71(7), 1086-1091. (Pubitemid 46998024)
42. Karpinski, L., Plaksej, R., Derzhko, R., Orda, A., & Witkowska, M. (2009). Serum levels of interleukin-6, interleukin-10 and Creactive protein in patients with myocardial infarction treated with primary angioplasty during a 6-month follow-up. Polskie Archiwum Medycyny Wewnȩtrznej, 119(3), 115-121.
43. Kempf, T., Eden, M., Strelau, J., Naguib, M., Willenbockel, C., Tongers, J., et al. (2006). The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circulation Research, 98 (3), 351-360. doi:10.1161/01.RES.0000202805. 73038.48.
44. Bujak, M., & Frangogiannis, N. G. (2007). The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovascular Research, 74(2), 184-195. doi :10.1016/j.cardiores.2006.10.002. (Pubitemid 46517504)
45. Haeusler, K. G., Schmidt, W. U., Foehring, F., Meisel, C., Guenther, C., Brunecker, P., et al. (2010). Immune responses after acute ischemic stroke or myocardial infarction. International Journal of Cardiology. doi:10.1016/j. ijcard.2010.10.053.
46. Hansson, G. K., & Libby, P. (2006). The immune response in atherosclerosis: A double-edged sword. Nature Reviews Immunology, 6(7), 508-519. doi:10.1038/nri1882. (Pubitemid 43980523)
47. Cheng, X., Liao, Y. H., Ge, H., Li, B., Zhang, J., Yuan, J., et al. (2005). TH1/TH2 functional imbalance after acute myocardial infarction: Coronary arterial inflammation or myocardial inflammation. Journal of Clinical Immunology, 25(3), 246-253. doi:10.1007/s10875-005-4088-0. (Pubitemid 40884051)
48. Steppich, B. A., Moog, P., Matissek, C.,Wisniowski, N., Kuhle, J., Joghetaei, N., et al. (2007). Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis, 190(2), 443-451. doi:10.1016/j. atherosclerosis.2006.02.034. (Pubitemid 46074036)
49. Bodi, V., Sanchis, J., Nunez, J., Mainar, L., Minana, G., Benet, I., et al. (2008). Uncontrolled immune response in acute myocardial infarction: unraveling the thread. American Heart Journal, 156(6), 1065-1073. doi:10.1016/j.ahj.2008.07.008.
50. Sardella, G., De Luca, L., Francavilla, V., Accapezzato, D., Mancone, M., Sirinian, M. I., et al. (2007). Frequency of naturally-occurring regulatory T cells is reduced in patients with ST-segment elevation myocardial infarction. Thrombosis Research, 120(4), 631-634. doi:10.1016/j.thromres.2006.12.005. (Pubitemid 47094917)
51. Han, S. F., Liu, P., Zhang, W., Bu, L., Shen, M., Li, H., et al. (2007). The opposite-direction modulation of CD4+ CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clinical Immunology, 124(1), 90-97. doi :10.1016/j.clim.2007.03.546. (Pubitemid 46936250)
52. Ammirati, E., Cianflone, D., Banfi, M., Vecchio, V., Palini, A., De Metrio, M., et al. (2010). Circulating CD4+ CD25hiCD127lo regulatory T-cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(9), 1832-1841. doi:10.1161/ATVBAHA.110.206813.
53. Mor, A., Luboshits, G., Planer, D., Keren, G., & George, J. (2006). Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. European Heart Journal, 27(21), 2530-2537. doi:10.1093/eurheartj/ehl222. (Pubitemid 44627295)
54. de Boer, O. J., van derMeer, J. J., Teeling, P., van der Loos, C. M., & van derWal, A. C. (2007). Low numbers of FOXP3 positive regulatory Tcells are present in all developmental stages of human atherosclerotic lesions. PloS One, 2(8), e779. doi:10.1371/journal.pone.0000779 (Pubitemid 351385866)